Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2026-01-31 @ 6:52 AM
Study NCT ID:
NCT02649361
Status:
COMPLETED
Last Update Posted:
2019-06-05
First Post:
2016-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALTN-11-II
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None